{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:19:04Z","timestamp":1791278344797,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The sulfation pattern of heparan sulfate chains influences signaling events mediated by heparan sulfate proteoglycans located on cell surface. SULF1 and SULF2 are two endosulfatases able to cleave specific 6-O sulfate groups within the heparan chains. Their action can modulate signaling processes, many of which with key relevance for cancer development and expansion. SULF1 has been associated with tumor suppressor effects in various models of cancer, whereas SULF2 dysregulation was in relation with protumorigenic actions. However, other observations argue for contradictory effects of these sulfatases in cancer, suggesting the complexity of their action in the tumor microenvironment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We compared the expression of the genes encoding SULF1, SULF2 and heparan sulfate proteoglycans in a large panel of cancer samples to their normal tissue counterparts using publicly available gene expression data, including the data obtained from two cohorts of newly-diagnosed multiple myeloma patients, the Oncomine Cancer Microarray database, the Amazonia data base and the ITTACA database. We also analysed prognosis data in relation with these databases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We demonstrated that <jats:italic>SULF2<\/jats:italic> expression in primary multiple myeloma cells was associated with a poor prognosis in two independent large cohorts of patients. It remained an independent predictor when considered together with conventional multiple myeloma prognosis factors. Besides, we observed an over-representation of <jats:italic>SULF2<\/jats:italic> gene expression in skin cancer, colorectal carcinoma, testicular teratoma and liver cancer compared to their normal tissue counterpart. We found that <jats:italic>SULF2<\/jats:italic> was significantly over-expressed in high grade uveal melanoma compared to low grade and in patients presenting colorectal carcinoma compared to benign colon adenoma.<\/jats:p>\n            <jats:p>We observed that, in addition to previous observations, <jats:italic>SULF1<\/jats:italic> gene expression was increased in T prolymphocytic leukemia, acute myeloid leukemia and in renal carcinoma compared to corresponding normal tissues. Furthermore, we found that high <jats:italic>SULF1<\/jats:italic> expression was associated with a poor prognosis in lung adenocarcinoma.<\/jats:p>\n            <jats:p>Finally, <jats:italic>SULF1<\/jats:italic> and <jats:italic>SULF2<\/jats:italic> were simultaneously overexpressed in 6 cancer types: brain, breast, head and neck, renal, skin and testicular cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n              <jats:italic>SULF1<\/jats:italic> and <jats:italic>SULF2<\/jats:italic> are overexpressed in various human cancer types and can be associated to progression and prognosis. Targeting SULF1 and\/or SULF2 could be interesting strategies to develop novel cancer therapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-5876-9-72","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T18:17:14Z","timestamp":1306001834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["SULFs in human neoplasia: implication as progression and prognosis factors"],"prefix":"10.1186","volume":"9","author":[{"given":"Caroline","family":"Bret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Moreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Schved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,21]]},"reference":[{"key":"734_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1367-5931(00)00145-9","volume":"4","author":"R Sasisekharan","year":"2000","unstructured":"Sasisekharan R, Venkataraman G: Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol. 2000, 4: 626-631. 10.1016\/S1367-5931(00)00145-9.","journal-title":"Curr Opin Chem Biol"},{"key":"734_CR2","doi-asserted-by":"publisher","first-page":"49175","DOI":"10.1074\/jbc.M205131200","volume":"277","author":"M Morimoto-Tomita","year":"2002","unstructured":"Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD: Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem. 2002, 277: 49175-49185. 10.1074\/jbc.M205131200.","journal-title":"J Biol Chem"},{"key":"734_CR3","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1371\/journal.pone.0000575","volume":"2","author":"CR Holst","year":"2007","unstructured":"Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, Chalasani S, Carano RA, Frantz GD, Tessier-Lavigne M, Bolon B: Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS One. 2007, 2: e575-10.1371\/journal.pone.0000575.","journal-title":"PLoS One"},{"key":"734_CR4","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1111\/j.1582-4934.2008.00558.x","volume":"13","author":"I Kalus","year":"2009","unstructured":"Kalus I, Salmen B, Viebahn C, von Figura K, Schmitz D, D'Hooge R, Dierks T: Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity. J Cell Mol Med. 2009, 13: 4505-4521. 10.1111\/j.1582-4934.2008.00558.x.","journal-title":"J Cell Mol Med"},{"key":"734_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004, 6: 1-6.","journal-title":"Neoplasia"},{"key":"734_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1634\/stemcells.2006-0352","volume":"25","author":"S Assou","year":"2007","unstructured":"Assou S, Le Carrour T, Tondeur S, Strom S, Gabelle A, Marty S, Nadal L, Pantesco V, Reme T, Hugnot JP: A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells. 2007, 25: 961-973. 10.1634\/stemcells.2006-0352.","journal-title":"Stem Cells"},{"key":"734_CR7","doi-asserted-by":"publisher","first-page":"D613","DOI":"10.1093\/nar\/gkj022","volume":"34","author":"A Elfilali","year":"2006","unstructured":"Elfilali A, Lair S, Verbeke C, La Rosa P, Radvanyi F, Barillot E: ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res. 2006, 34: D613-616. 10.1093\/nar\/gkj022.","journal-title":"Nucleic Acids Res"},{"key":"734_CR8","doi-asserted-by":"publisher","first-page":"23107","DOI":"10.1074\/jbc.M302203200","volume":"278","author":"J Lai","year":"2003","unstructured":"Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR, Shridhar V: Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem. 2003, 278: 23107-23117. 10.1074\/jbc.M302203200.","journal-title":"J Biol Chem"},{"key":"734_CR9","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1038\/sj.onc.1210300","volume":"26","author":"J Staub","year":"2007","unstructured":"Staub J, Chien J, Pan Y, Qian X, Narita K, Aletti G, Scheerer M, Roberts LR, Molina J, Shridhar V: Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance. Oncogene. 2007, 26: 4969-4978. 10.1038\/sj.onc.1210300.","journal-title":"Oncogene"},{"key":"734_CR10","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/0008-5472.CAN-08-3065","volume":"69","author":"P Liu","year":"2009","unstructured":"Liu P, Khurana A, Rattan R, He X, Kalloger S, Dowdy S, Gilks B, Shridhar V: Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer. Cancer Res. 2009, 69: 4843-4850. 10.1158\/0008-5472.CAN-08-3065.","journal-title":"Cancer Res"},{"key":"734_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2217\/14796694.4.6.803","volume":"4","author":"JP Lai","year":"2008","unstructured":"Lai JP, Thompson JR, Sandhu DS, Roberts LR: Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Future Oncol. 2008, 4: 803-814. 10.2217\/14796694.4.6.803.","journal-title":"Future Oncol"},{"key":"734_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ijc.23960","volume":"124","author":"Z Chen","year":"2009","unstructured":"Chen Z, Fan JQ, Li J, Li QS, Yan Z, Jia XK, Liu WD, Wei LJ, Zhang FZ, Gao H: Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer. Int J Cancer. 2009, 124: 739-744. 10.1002\/ijc.23960.","journal-title":"Int J Cancer"},{"key":"734_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jcp.20828","volume":"210","author":"H Zhao","year":"2007","unstructured":"Zhao H, Ramos CF, Brooks JD, Peehl DM: Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. J Cell Physiol. 2007, 210: 111-121. 10.1002\/jcp.20828.","journal-title":"J Cell Physiol"},{"key":"734_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/sj.onc.1207258","volume":"23","author":"JP Lai","year":"2004","unstructured":"Lai JP, Chien J, Strome SE, Staub J, Montoya DP, Greene EL, Smith DI, Roberts LR, Shridhar V: HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene. 2004, 23: 1439-1447. 10.1038\/sj.onc.1207258.","journal-title":"Oncogene"},{"key":"734_CR15","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1242\/dev.007674","volume":"134","author":"X Ai","year":"2007","unstructured":"Ai X, Kitazawa T, Do AT, Kusche-Gullberg M, Labosky PA, Emerson CP: SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development. 2007, 134: 3327-3338. 10.1242\/dev.007674.","journal-title":"Development"},{"key":"734_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ydbio.2007.08.053","volume":"311","author":"A Langsdorf","year":"2007","unstructured":"Langsdorf A, Do AT, Kusche-Gullberg M, Emerson CP, Ai X: Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev Biol. 2007, 311: 464-477. 10.1016\/j.ydbio.2007.08.053.","journal-title":"Dev Biol"},{"key":"734_CR17","doi-asserted-by":"publisher","first-page":"27724","DOI":"10.1074\/jbc.M802130200","volume":"283","author":"WC Lamanna","year":"2008","unstructured":"Lamanna WC, Frese MA, Balleininger M, Dierks T: Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem. 2008, 283: 27724-27735. 10.1074\/jbc.M802130200.","journal-title":"J Biol Chem"},{"key":"734_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.gastro.2003.09.043","volume":"126","author":"JP Lai","year":"2004","unstructured":"Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP, Matthews TA, Nagorney DM, Cunningham JM, Smith DI: hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology. 2004, 126: 231-248. 10.1053\/j.gastro.2003.09.043.","journal-title":"Gastroenterology"},{"key":"734_CR19","doi-asserted-by":"publisher","first-page":"14413","DOI":"10.1074\/jbc.M611395200","volume":"282","author":"K Narita","year":"2007","unstructured":"Narita K, Chien J, Mullany SA, Staub J, Qian X, Lingle WL, Shridhar V: Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. J Biol Chem. 2007, 282: 14413-14420. 10.1074\/jbc.M611395200.","journal-title":"J Biol Chem"},{"key":"734_CR20","doi-asserted-by":"publisher","first-page":"40066","DOI":"10.1074\/jbc.M508136200","volume":"280","author":"Y Dai","year":"2005","unstructured":"Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z, Venkataraman G, Sasisekharan R, Sanderson RD: HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem. 2005, 280: 40066-40073. 10.1074\/jbc.M508136200.","journal-title":"J Biol Chem"},{"key":"734_CR21","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1158\/0008-5472.CAN-05-3582","volume":"66","author":"K Narita","year":"2006","unstructured":"Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V: HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res. 2006, 66: 6025-6032. 10.1158\/0008-5472.CAN-05-3582.","journal-title":"Cancer Res"},{"key":"734_CR22","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1053\/j.gastro.2006.02.056","volume":"130","author":"JP Lai","year":"2006","unstructured":"Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, Murphy LM, Garrity-Park MM, Shridhar V, Adjei AA, Roberts LR: SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma. Gastroenterology. 2006, 130: 2130-2144. 10.1053\/j.gastro.2006.02.056.","journal-title":"Gastroenterology"},{"key":"734_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jhep.2008.12.031","volume":"50","author":"JP Lai","year":"2009","unstructured":"Lai JP, Sandhu DS, Moser CD, Cazanave SC, Oseini AM, Shire AM, Shridhar V, Sanderson SO, Roberts LR: Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. J Hepatol. 2009, 50: 1112-1121. 10.1016\/j.jhep.2008.12.031.","journal-title":"J Hepatol"},{"key":"734_CR24","doi-asserted-by":"crossref","unstructured":"Lemjabbar-Alaoui H, van Zante A, Singer MS, Xue Q, Wang YQ, Tsay D, He B, Jablons DM, Rosen SD: Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Oncogene. 29: 635-646. 10.1038\/onc.2009.365.","DOI":"10.1038\/onc.2009.365"},{"key":"734_CR25","doi-asserted-by":"crossref","unstructured":"Sethi JK, Vidal-Puig A: Wnt signalling and the control of cellular metabolism. Biochem J. 427: 1-17. 10.1042\/BJ20091866.","DOI":"10.1042\/BJ20091866"},{"key":"734_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1593\/neo.05496","volume":"7","author":"M Morimoto-Tomita","year":"2005","unstructured":"Morimoto-Tomita M, Uchimura K, Bistrup A, Lum DH, Egeblad M, Boudreau N, Werb Z, Rosen SD: Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia. 2005, 7: 1001-1010. 10.1593\/neo.05496.","journal-title":"Neoplasia"},{"key":"734_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2141.2009.07633.x","volume":"145","author":"C Bret","year":"2009","unstructured":"Bret C, Hose D, Reme T, Sprynski AC, Mahtouk K, Schved JF, Quittet P, Rossi JF, Goldschmidt H, Klein B: Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells. Br J Haematol. 2009, 145: 350-368. 10.1111\/j.1365-2141.2009.07633.x.","journal-title":"Br J Haematol"},{"key":"734_CR28","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B: The molecular classification of multiple myeloma. Blood. 2006, 108: 2020-2028. 10.1182\/blood-2005-11-013458.","journal-title":"Blood"},{"key":"734_CR29","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","volume":"113","author":"AC Sprynski","year":"2009","unstructured":"Sprynski AC, Hose D, Caillot L, Reme T, Shaughnessy JD, Barlogie B, Seckinger A, Moreaux J, Hundemer M, Jourdan M: The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor. Blood. 2009, 113: 4614-4626. 10.1182\/blood-2008-07-170464.","journal-title":"Blood"},{"key":"734_CR30","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"JD Shaughnessy Jr","year":"2007","unstructured":"Shaughnessy JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR: A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 110.1182\/blood-2006-07-038430. Blood. 2007, 109: 2276-2284. 10.1182\/blood-2006-07-038430.","journal-title":"Blood"},{"key":"734_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2010.030296","volume":"96","author":"D Hose","year":"2011","unstructured":"Hose D, Reme T, Hielscher T, Moreaux J, Messner T, Seckinger A, Benner A, Shaughnessy JD, Barlogie B, Zhou Y: Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. Haematologica. 2011, 96: 87-95. 10.3324\/haematol.2010.030296.","journal-title":"Haematologica"},{"key":"734_CR32","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux O, Lode L, Magrangeas F, Charbonnel C, Gouraud W, Jezequel P, Attal M, Harousseau JL, Moreau P, Bataille R: Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome. J Clin Oncol. 2008, 26: 4798-4805. 10.1200\/JCO.2007.13.8545.","journal-title":"J Clin Oncol"},{"key":"734_CR33","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","volume":"108","author":"J Moreaux","year":"2006","unstructured":"Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E, Moine P, Bourin P, Moos M, Corre J: CD200 is a new prognostic factor in multiple myeloma. Blood. 2006, 108: 4194-4197. 10.1182\/blood-2006-06-029355.","journal-title":"Blood"},{"key":"734_CR34","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B: The molecular classification of multiple myeloma 10.1182\/blood-2005-11-013458. Blood. 2006, 108: 2020-2028. 10.1182\/blood-2005-11-013458.","journal-title":"Blood"},{"key":"734_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.22202","volume":"47","author":"JP Lai","year":"2008","unstructured":"Lai JP, Sandhu DS, Yu C, Han T, Moser CD, Jackson KK, Guerrero RB, Aderca I, Isomoto H, Garrity-Park MM: Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology. 2008, 47: 1211-1222. 10.1002\/hep.22202.","journal-title":"Hepatology"},{"key":"734_CR36","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1371\/journal.pone.0000392","volume":"2","author":"R Nawroth","year":"2007","unstructured":"Nawroth R, van Zante A, Cervantes S, McManus M, Hebrok M, Rosen SD: Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS One. 2007, 2: e392-10.1371\/journal.pone.0000392.","journal-title":"PLoS One"},{"key":"734_CR37","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1038\/sj.onc.1208553","volume":"24","author":"FK Johansson","year":"2005","unstructured":"Johansson FK, Goransson H, Westermark B: Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene. 2005, 24: 3896-3905. 10.1038\/sj.onc.1208553.","journal-title":"Oncogene"},{"key":"734_CR38","doi-asserted-by":"crossref","unstructured":"Moussay E, Palissot V, Vallar L, Poirel HA, Wenner T, El-Khoury V, Aouali N, van Moer K, Leners B, Bernardin F: Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer. 9: 115-10.1186\/1476-4598-9-115.","DOI":"10.1186\/1476-4598-9-115"},{"key":"734_CR39","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/14728222.2010.504718","volume":"14","author":"SD Rosen","year":"2010","unstructured":"Rosen SD, Lemjabbar-Alaoui H: Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets. 2010, 14: 935-949. 10.1517\/14728222.2010.504718.","journal-title":"Expert Opin Ther Targets"},{"key":"734_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8794-1-13","volume":"1","author":"AI Riker","year":"2008","unstructured":"Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 2008, 1: 13-10.1186\/1755-8794-1-13.","journal-title":"BMC Med Genomics"},{"key":"734_CR41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1556\/OH.2008.28397","volume":"149","author":"O Galamb","year":"2008","unstructured":"Galamb O: mRNA expression analysis and classification of colonic biopsy samples using oligonucleotide and cDNA microarray techniques. Orv Hetil. 2008, 149: 1373-1377. 10.1556\/OH.2008.28397.","journal-title":"Orv Hetil"},{"key":"734_CR42","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-05-0153","volume":"65","author":"RI Skotheim","year":"2005","unstructured":"Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA: Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res. 2005, 65: 5588-5598. 10.1158\/0008-5472.CAN-05-0153.","journal-title":"Cancer Res"},{"key":"734_CR43","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep.21622","volume":"45","author":"E Wurmbach","year":"2007","unstructured":"Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J: Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007, 45: 938-947. 10.1002\/hep.21622.","journal-title":"Hepatology"},{"key":"734_CR44","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/sj.leu.2404877","volume":"21","author":"J Durig","year":"2007","unstructured":"Durig J, Bug S, Klein-Hitpass L, Boes T, Jons T, Martin-Subero JI, Harder L, Baudis M, Duhrsen U, Siebert R: Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia. 2007, 21: 2153-2163. 10.1038\/sj.leu.2404877.","journal-title":"Leukemia"},{"key":"734_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ng1305","volume":"36","author":"K Stegmaier","year":"2004","unstructured":"Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR: Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation. Nat Genet. 2004, 36: 257-263. 10.1038\/ng1305.","journal-title":"Nat Genet"},{"key":"734_CR46","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1158\/1078-0432.CCR-07-0143","volume":"13","author":"ML Gumz","year":"2007","unstructured":"Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS: Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res. 2007, 13: 4740-4749. 10.1158\/1078-0432.CCR-07-0143.","journal-title":"Clin Cancer Res"},{"key":"734_CR47","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 2001, 98: 13790-13795. 10.1073\/pnas.191502998.","journal-title":"Proc Natl Acad Sci USA"},{"key":"734_CR48","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(03)13308-9","volume":"361","author":"E Huang","year":"2003","unstructured":"Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM: Gene expression predictors of breast cancer outcomes. Lancet. 2003, 361: 1590-1596. 10.1016\/S0140-6736(03)13308-9.","journal-title":"Lancet"},{"key":"734_CR49","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003, 100: 8418-8423. 10.1073\/pnas.0932692100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"734_CR50","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/jcp.2005.031716","volume":"59","author":"I Abiatari","year":"2006","unstructured":"Abiatari I, Kleeff J, Li J, Felix K, Buchler MW, Friess H: Hsulf-1 regulates growth and invasion of pancreatic cancer cells. J Clin Pathol. 2006, 59: 1052-1058. 10.1136\/jcp.2005.031716.","journal-title":"J Clin Pathol"},{"key":"734_CR51","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.yexcr.2009.06.029","volume":"315","author":"AP Sahota","year":"2009","unstructured":"Sahota AP, Dhoot GK: A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity. Exp Cell Res. 2009, 315: 2752-2764. 10.1016\/j.yexcr.2009.06.029.","journal-title":"Exp Cell Res"},{"key":"734_CR52","first-page":"1491","volume":"31","author":"BL Adamsen","year":"2007","unstructured":"Adamsen BL, Kravik KL, Clausen OP, De Angelis PM: Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Int J Oncol. 2007, 31: 1491-1500.","journal-title":"Int J Oncol"},{"key":"734_CR53","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1158\/0008-5472.CAN-08-2742","volume":"69","author":"BN Chau","year":"2009","unstructured":"Chau BN, Diaz RL, Saunders MA, Cheng C, Chang AN, Warrener P, Bradshaw J, Linsley PS, Cleary MA: Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analyses. Cancer Res. 2009, 69: 1368-1374. 10.1158\/0008-5472.CAN-08-2742.","journal-title":"Cancer Res"},{"key":"734_CR54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/03008200802143281","volume":"49","author":"I Vlodavsky","year":"2008","unstructured":"Vlodavsky I, Elkin M, Abboud-Jarrous G, Levi-Adam F, Fuks L, Shafat I, Ilan N: Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res. 2008, 49: 207-210. 10.1080\/03008200802143281.","journal-title":"Connect Tissue Res"},{"key":"734_CR55","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken MD, Worley LA, Ehlers JP, Harbour JW: Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004, 64: 7205-7209. 10.1158\/0008-5472.CAN-04-1750.","journal-title":"Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T14:05:42Z","timestamp":1630505142000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-9-72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,21]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-9-72","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,21]]},"assertion":[{"value":"29 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}